| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Khing Djien Oei | Director | 2026-09-25 | 168,750 | $3.92 | $661.50kSell |
| Patricia A. Martin | Director | 2026-09-23 | 50,000 | $3.86 | $193.00kSell |
| Thomas John Dietz | Director | 2026-08-26 | 20,000 | $1.72 | $34.40kSell |
| William Patrick McEvoy Iii | CIO | 2026-08-17 | 16,570,852 | $0.00 | $16.57kBuy |
| Winklevoss Capital Fund LLC | 10% Owner | 2026-08-17 | 16,570,852 | $0.00 | $16.57kBuy |
| Christopher Mirabelli | Director | 2026-03-26 | 60,000 | $0.71 | $42.66kSell |
| Thomas John Dietz | Director | 2025-12-26 | 35,000 | $1.20 | $42.00kSell |
| Christopher Mirabelli | Director | 2025-11-17 | 414,479 | $3.14 | $1.30MSell |
| Christopher Mirabelli | Director | 2025-11-17 | 261,840 | $3.14 | $822.18kSell |
| James H. Cavanaugh | Director | 2025-11-17 | 261,840 | $3.14 | $822.18kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Winklevoss Capital Fund LLC | 30.75% | 33,138,374 | $107.04M | Insider |
| William Patrick McEvoy Iii | 30.75% | 33,138,374 | $107.04M | Insider |
| Perceptive Advisors LLC | 7.87% | 8,476,496 | $27.38M | Insider |
| Beigene Ltd | 6.82% | 7,348,437 | $23.74M | Insider |
| Gilead Sciences Inc | 4.94% | 5,319,148 | $17.18M | Insider |
| Healthcare Ventures IX LP | 3.85% | 4,144,804 | $13.39M | Insider |
| John W. Littlechild | 2.43% | 2,618,406 | $8.46M | Insider |
| Augustine Lawlor | 1.59% | 1,718,454 | $5.55M | Insider |
| Lilly Co Eli | 1.37% | 1,479,307 | $4.78M | Insider |
| Christopher Mirabelli | 0.82% | 888,745 | $2.87M | Insider |